Side Effects of Tasigna Cancer Drug Include Atherosclerosis and Peripheral Artery Disease
Physical signs to look for it you suspect you have developed atherosclerosis or peripheral arterial disease
Friday, September 15, 2017 - If you have Chronic Myeloid Leukemia (CML) and have been treated with the drug Tasigna, chances are you will develop atherosclerosis, a thickening and hardening of the arteries leading to the arms, legs and vital internal organs like the brain and heart and your life could be in danger. Studies indicate that a person receiving Tasigna treatments is roughly five times more likely to develop peripheral artery disease than cancer patients receiving other types of chemotherapy treatments. As a result, you may qualify to seek real monetary compensation by suing the maker of Tasigna, pharmaceutical giant Novartis AG.
Chemotherapy drug Tasigna is now linked with cases of atherosclerosis, amputation, and sudden death as well as paralysis from strokes. Tasigna causes atherosclerosis which lessens the circulation of vital, oxygen-rich blood and can cause necrosis and tissue death requiring amputation. Other health complications from Tasigna include heart attack and strokes.
Another potentially deadly side effects of Tasigna is peripheral artery disease (PAD). Physical signs to look for that could indicate PAD are muscle cramps when walking or walking up stairs, abnormal lesions on your on your legs and feet that do not heal normally, blackening of the toes caused by tissue death (necrosis), thick ugly yellow toenail discoloration, and men may experience erectile dysfunction. Coldness, tingling, and numbness in the legs and feet are other signs of PAD.
If you are experiencing chest pain or tightness, or shortness of breath, you may have developed coronary artery disease that could lead to heart failure or heart attack.
People suffering from atherosclerosis and PAD are suing Novartis alleging that the company knew of the deadly risks of Tasigna yet did nothing to warn the American Cancer medical community. As a result, thousands of patients were given Tasigna and many are now developing the symptoms of, and many have died from heart disease, heart attack, and strokes. Tasigna patients have also had to have limbs amputated.
Tasigna lawyers at Onder, Shelton, O'Leary & Peterson, LLC, represent clients in all 50 states in litigation against Tasigna maker Novartis AG. The firm is knowledgeable and experienced in the area of product liability law pertaining to dangerous drugs. The firm is particularly zealous when representing families that have been torn asunder by the negligence and greed of giant pharmaceutical companies and seek massive punitive damages not only to compensate our clients but also to alert the public of the dangers of Tasigna as Novartis has failed to do so. Tasigna manufacturer and marketer Novartis knowingly hid the Tasigna risk information from the American public, all the while aggressively and unethically marketing the drug. Novartis marketing executive made payments of illegal kickbacks to promote the drug. Persons harmed by Tasigna atherosclerosis or another Tasigna complication may be eligible for real compensation by filing a lawsuit against Novartis.
Onder, Shelton, O'Leary & Peterson, LLC has won hundreds of millions of dollars for plaintiffs that have been injured or died as a result of companies that fail to warn the public of the deadly diseases their product causes. If you suffer from atherosclerosis, peripheral artery disease or any coronary-related debilitating condition after you have been given Tasigna, call Onder, Shelton, O'Leary & Peterson, LLC today.
More Recent Tasigna Atherosclerosis Lawsuit News:
- Tasigna Patients Are Warned of The Risk of Sudden Death | 5/13/2019
- Tasigna's Atherosclerosis Risk Is Well-Documented By Researchers For Peer-Reviewed Medical Publications | 5/8/2019
- Tasigna's Atherosclerosis Side Effect Is Not Forgotten | 4/17/2019
- Trying Tasigna As A Last Resort May Make Sense To Terminally Ill Cancer Patients | 4/12/2019
- Novartis Claim Tasigna Can Help Parkinson's Patients is Met With Skepticism | 4/4/2019
- Novartis Failed To Warn American Doctors Who In Turn Failed To Warn Patients of Tasigna's Atherosclerosis Risks | 3/20/2019
- Tasigna Is Being Repurposed To Treat Parkinson's Disease | 3/14/2019
- Some Patient Can Cease Taking Tasigna But They May Have Already Developed Atherosclerosis | 3/12/2019
- Health Experts Warn of Potentially Deadly Tasigna Drug Interactions | 3/5/2019
- The Potential To Someday Stop Tasigna Treatments Should Not Be An Incentive To Take The Drug | 2/28/2019
- Tasigna Studies Show The Drug Should Be Taken As A Last Resort | 2/24/2019
- Cancer Doctors and Medical Websites Should Take Tasigna's Atherosclerosis Risks More Seriously | 2/18/2019
- The FDA May Be Putting Children's Lives In Danger By Ignoring Tasigna's Atherosclerosis Risk | 2/12/2019
- The FDA May Have Overlooked Tasigna's Atherosclerosis Side Effect When Approving its Usage by Children | 2/5/2019
- Children With Cancer May Now Start Taking Tasigna | 1/31/2019
- Studies Reported by Leading Experts Focus on Tasigna Toxicity | 1/25/2019
- Novartis Has a History of Deceptive Sale Practices That Taints Their Credibility | 1/22/2019
- Novartis Changes Tasigna's Label But Not Its Toxicity | 1/16/2019
- Tasigna Doctors May Be Ignoring Atherosclerosis Risks | 1/11/2019
- Cancer Doctors Prescribing Tasigna Should Be Trained Like Heart Specialists | 1/8/2019
- Tasigna is Effective in Treating Chronic Myeloid Leukemia | 1/1/2019
- Early Warning Signs of Chronic Myeloid Leukemia (CML) | 12/5/2018
- CML Patients in Remission May Discontinue Taking Tasigna | 12/1/2018
- Tasigna's Atherosclerosis Warnings is Rarely Seen by Cancer Patients | 11/28/2018
- Novartis' Failure to Warn the FDA May Have Led to Atherosclerosis in As Many As One in Four Tasigna Patients | 11/12/2018
- Novartis Highlights Tasigna's Effectiveness yet Downplays The Drug's Deadly Side Effects | 11/8/2018
- Novartis Takes Advantage of Tasigna's Catch 22 | 10/30/2018
- Tasigna Atherosclerosis Ignored by Novartis Celebrity Spokesperson | 10/24/2018
- Oncologists May Be Ignoring the Cardiovascular Side Effects of Tasigna | 10/16/2018
- The FDA Atherosclerosis Warning Came Too Late for Tasigna Patients in the United States | 10/8/2018
- One-Third of Tasigna Patients Could Face Coronary Bypass Surgery | 10/4/2018
- Billion Dollar Fines Are Just a Cost of Doing Business For Novartis | 10/2/2018
- Cancer Patients Should View Novartis' New Tasigna Label With Scepticism | 9/28/2018
- Novartis Boasts of Tasigna's Effectiveness While Ignoring the Atherosclerosis Side Effects | 9/27/2018
- Tasigna May Be One Of The Most Deadly Drugs On The Market Today | 9/25/2018
- NBA Star's Arterial Blockage May Have Been Caused by Taking Tasigna | 9/22/2018
- Taxpayers Saved Billions By Novartis AG Whistleblower | 9/20/2018
- Tasigna Carries The Unacceptable Risk of Developing Atherosclerosis and Amputation | 9/19/2018
- Tasigna's Cancer-Fighting Success May Be Tempered By The Risk Of Sudden Death | 9/17/2018
- Novartis Pulled No Punches In Warning Canadians About The Atherosclerosis Related Side effects Of Tasigna Yet Said Nothing To Warn Cancer Patients In The United States. | 9/11/2018
- Novartis is a Repeat Offender for Fraudulent Drug Marketing | 8/29/2018
- Peripheral Artery Disease Plagues Tasigna Patients | 8/27/2018
- Patients Could Have Benefited From Gleevec's Generic Alternative | 8/21/2018
- Novartis/Tasigna Lawsuit May Seek Punitive Damages | 8/17/2018
- Tasigna Atherosclerosis Trial Set to Proceed | 8/14/2018
- Medical Websites Ignore Tasigna's Risks | 8/10/2018
- Novartis haste in rushing Tasigna to market has cost patients their lives | 8/8/2018
- Tasigna's Side Effects Require Special Attention From Prospective Patients | 8/6/2018
- Novartis Whistleblower Receives $12 Million For His Efforts | 7/31/2018
- Tasigna Atherosclerosis Hidden From Americans | 7/30/2018
- Gleevec Was a Cancer-Curing Miracle Drug | 7/26/2018
- Tasigna Stroke Victim's Trial to Proceed in Florida | 7/24/2018
- Novartis Employee Blows Whistle on Tasigna Fraud and Others | 7/20/2018
- Tasigna Side Effects Are Worse Than Cancer | 7/18/2018
- Tasigna Cancer Medication Carries More Risks Than Others | 7/11/2018
- Specialty Pharmacists Bribed to Prescribe Tasigna | 7/6/2018
- Novartis Billion-Dollar Fine for Fraudulent Marketing Tactics | 7/2/2018
- Tasigna Black Box Warning Addendum | 6/29/2018
- Tasigna Replaced Gleevec and Patients Suffered | 6/25/2018
- Specialty Pharmacists Selling Tasigna Compromised Ethical Standards | 6/20/2018
- US Department of Justice Fines Novartis One Billion Dollars | 6/13/2018
- Tasigna Sudden Death Warning | 6/11/2018
- Tasigna Cancer Treatment Poses Scary Risks | 6/7/2018
- Novartis Fraudulent Marketing Deception | 5/29/2018
- Tasigna Atherosclerosis Warning Never Made it to the US | 5/25/2018
- Novartis Tasigna Anti-Cancer Drug Has Side Effects That Include Sudden Death | 5/22/2018
- Tasigna Replaced Gleevec Under Fraudulent Circumstance | 5/18/2018
- Novartis Held Accountable For Concealing Tasigna Atherosclerosis Risk | 5/15/2018
- Tasigna Chemotherapy Carries a Sudden Death Warning | 5/10/2018
- Novartis Warns That Tasigna Can Cause Atherosclerosis | 5/6/2018
- Tasigna Poses Atherosclerosis Amputations Risk | 5/3/2018
- Tasigna Rushed to Market to Replace Gleevec | 12/29/2017
- Whistleblower Saves American Taxpayers Millions | 12/22/2017
- Gleevec-the Novartis AG Wonder Drug | 12/20/2017
- Tasigna Warnings | 12/18/2017
- Tasignas Black Box Warning Links The Drug To Atherosclerosis | 12/15/2017
- Novartis Fails To Warn The U.S. Medical Community About The Side Effects of Tasigna | 12/11/2017
- Tasigna Replaces Gleevec as the Novartis AGs Signature Anti-Cancer Chemotherapy Drug | 12/6/2017
- The Unmistakable Signs of Peripheral Artery Disease | 12/1/2017
- Whistleblower Causes Public Alert to Tasigna Side Effects | 11/27/2017
- The Estate of a California Man is Suing Novartis | 11/20/2017
- Ex-Novartis Salesmanager Blows The Whistle On Illegal Drug Marketing | 11/13/2017
- U.S. Cancer Patients Receive Tasigna Atherosclerosis Warning | 11/6/2017
- Novartis Marketed Tasigna to Replace Gleevec | 11/3/2017
- Leukemia Patients May Suffer From Heart Disease as Well | 10/30/2017
- Novartis' Potentially Misleading Drug Marketing Campaign | 10/23/2017
- Health Canada Issued a Tasigna Health Warning In 2013 | 10/16/2017
- Lawsuits Allege Novartis Was Aware of The Side Effects of Tasigna Yet Failed to Warn The American Public | 10/9/2017
- Tasigna Chemotherapy Atherosclerosis-related Side Effects | 10/2/2017
- The Onder Law Firm Seeks to Hold Novartis Accountable for the Suffering Tasigna Has Caused Families | 9/29/2017
- Novartis Fails to Warn About Tasigna Atherosclerosis | 9/22/2017
- Novartis Put Profits Ahead of Patients | 9/7/2017
- Novartis Failed to Warn the American Medical Community of the Side Effects of Tasigna | 9/1/2017
- Atherosclerosis Linked to Tasigna Anti Cancer Drug | 8/18/2017
- You Can Sue Novartis If You Have Developed Atherosclerosis-Related Conditions After Taking Tasigna | 8/11/2017
- Who Can Be Considered A Tasigna Victim | 8/4/2017
- Novartis AG makers of Tasigna Failed to Warn Public of the Dangerous Side Effects | 7/14/2017
- Tasigna Anti Cancer Drug Lawsuit | 7/7/2017
- Tasigna Drug Warning for Peripheral Arterial Disease | 6/30/2017
- Tasigna Cancer Treatment Drug Lawsuit | 6/26/2017
- Novartis International AG Lawsuits | 6/23/2017
- Lawsuits Against Novartis International AG Makers of Tasigna | 6/21/2017
- Tasigna Peripheral Artery Disease Warning | 6/19/2017
- Tasigna Lawsuits Against Drug Makers Novartis | 6/16/2017
- Atherosclerosis of the Aorta Linked to Tasigna Anti-Cancer Drug | 6/12/2017
- Makers of Tasigna Leukemia Drug Lawsuit | 6/9/2017
- Tasigna a Cancer Drug Treatment | 6/5/2017
- Tasigna Peripheral Arterial Disease | 6/1/2017
Lawyers for Tasigna Atherosclerosis Lawsuits
Attorneys handling Tasigna lawsuits for leukemia, non-Hodgkin lymphoma, and multiple myeloma offer free, no-obligation case review for individuals and families who believe they may have grounds to file a Tasigna lawsuit. Working on a contingency basis, these attorneys are committed to never charging legal fees unless they win compensation in your Tasigna lawsuit. The product liability litigators handling Roundup claims at the Onder Law Firm have a strong track record of success in representing families harmed by dangerous drugs and consumer products.